Filing Details

Accession Number:
0001209191-18-005831
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-29 16:19:55
Reporting Period:
2018-01-25
Accepted Time:
2018-01-29 16:19:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566044 Menlo Therapeutics Inc. MNLO Pharmaceutical Preparations (2834) 453757789
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627363 Remeditex Ventures Llc 2727 North Harwood, Suite 200
Dallas TX 75201
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-25 100,000 $17.00 1,582,854 No 4 P Direct
Common Stock Acquisiton 2018-01-29 2,650 $0.00 1,585,504 No 4 C Direct
Common Stock Acquisiton 2018-01-29 871,583 $0.00 2,457,087 No 4 C Direct
Common Stock Acquisiton 2018-01-29 304,576 $0.00 2,761,663 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2018-01-29 7,150 $0.00 2,650 $0.00
Common Stock Series B Preferred Stock Disposition 2018-01-29 2,351,097 $0.00 871,583 $0.00
Common Stock Series C Preferred Stock Disposition 2018-01-29 821,596 $0.00 304,576 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock.